휴머니젠의 예산영향모델, 코로나19 입원 환자에 대한 렌질루맙의 긍정적인 경제 가치를 입증 Humanigen, Inc. Oct 22, 2021 20:00 HKT/SGT Read More
Universities and DENSO Develop Biosensor to Detect SARS-CoV-2 and Accelerate Development for Practical Application Denso Oct 21, 2021 15:41 HKT/SGT Read More
Avance Clinical臨床試驗合作申辦方XWPharma正式開啟其XW10508首次人類臨床試驗,研究快速緩解難治性抑鬱症以及慢性疼痛療法 Avance Clinical Oct 19, 2021 15:00 HKT/SGT Read More
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain Avance Clinical Oct 19, 2021 15:00 HKT/SGT Read More
Avance Clinical临床试验合作申办方XWPharma正式开启其XW10508首次人类临床试验,研究快速缓解难治性抑郁症以及慢性疼痛疗法 Avance Clinical Oct 19, 2021 15:00 HKT/SGT Read More
エーザイとMSD、「レンビマ(R)」と「キイトルーダ(R)」の併用療法について進行性腎細胞がんおよび進行性子宮内膜がんに関する承認勧告を欧州医薬品委員会より受領 Eisai Oct 18, 2021 09:00 JST Read More
Eisai and Merck & Co., Inc. (Kenilworth, N.J.) Receive Positive EU CHMP Opinions for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Two Different Types of Cancer Eisai Oct 18, 2021 08:00 HKT/SGT Read More
Berjaya Partners Holista to Offer Healthy Breads and Foods in Starbucks Malaysia, 7-Eleven and Other F&B Outlets Holista CollTech Ltd Oct 12, 2021 17:00 HKT/SGT Read More
Legend Capital leads ForQaly Medical's Series B financing Legend Capital Oct 08, 2021 15:13 HKT/SGT Read More
CerbACT Asia Holds Ribbon Cutting to Celebrate New Immuno-oncology Centre of Excellence ACT Genomics Holdings Co., Ltd Oct 07, 2021 18:48 HKT/SGT Read More
휴머니젠, 사전에 계획된 렌질루맙의 판매 승인 신청(MAA) 제출과 관련된 단계의 일환으로 유럽의약품청(EMA)에서 조사위원 및 공동 조사위원을 지정했다고 발표함 Humanigen, Inc. Oct 04, 2021 16:00 HKT/SGT Read More
New treatment for severe corneal inflammation from DED now listed on PBS Seqirus, a CSL Company Oct 01, 2021 04:00 HKT/SGT Read More
Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer's Disease Under the Accelerated Approval Pathway Eisai Sep 28, 2021 10:37 HKT/SGT Read More